Progress in developing dopamine D3 ligands as potential antipsychotic agents

Current Pharmaceutical Design

Volumn 3, Issue 4, 1997, Pages 391-404

  Wustrow, David J ^a  

^a Division of Warner Lamber Company   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 DIPROPYLAMINO 1,2,3,4 TETRAHYDRO 6 (4 METHOXYPHENYLSULFONYLMETHYL)NAPHTHALENE; 2 DIPROPYLAMINO 5 METHOXY 1 METHYLTETRALIN; 2 DIPROPYLAMINO 5,6 DIMETHOXYINDAN; 2 DIPROPYLAMINO 7 HYDROXYTETRALIN; 3,4,4A,10B TETRAHYDRO 4 PROPYL 2H,5H [1]BENZOPYRANO[4,3 B][1,4]OXAZIN 9 OL; 4' ACETYL N [4 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]BUTYL]BIPHENYL 4 CARBOXAMIDE; 5 METHOXY 1 METHYL 2 PROPYLAMINOTETRALIN; 7 DIPROPYLAMINO 2,3,5,6,7,8 HEXAHYDRONAPHTHO[2,3 B]FURAN; APOMORPHINE; AUTORECEPTOR; BENZAMIDE DERIVATIVE; BROMOCRIPTINE; CLOZAPINE; DOPAMINE; DOPAMINE 3 RECEPTOR; DOPAMINE 3 RECEPTOR BLOCKING AGENT; ETICLOPRIDE; HALOPERIDOL; NAFADOTRIDE; NEUROLEPTIC AGENT; PD 155704; POSTSYNAPTIC RECEPTOR; PRAMIPEXOLE; QUINELORANE; QUINPIROLE; RACLOPRIDE; RECEPTOR SUBTYPE; SPIPERONE; SULPIRIDE; TETRALIN DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ARTICLE; DRUG DESIGN; DRUG RECEPTOR BINDING; LOCOMOTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; RECEPTOR AFFINITY; RECEPTOR DENSITY; RODENT; SCHIZOPHRENIA;

EID: 0030768589     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Spritzer, R. L.; Endicott, J.; Robins, E. Research and Diagnostic Criteria for a Selected Group of Functional Disorders; 3rd ed.; New York Psychiatric Institute: New York, N.Y., 1978.
2. Carlsson, A.; Lindqvist, M. Acta. Pharmacol. Toxicol. 1963, 20, 140-4.
3. Karobath, M.; Leittich, H. Proc. Natl. Acad. Sci. USA 1974, 71, 2915-8.
4. Creese, I.; Burl, D.; Snyder, S. H. Life Sci. 1975, 17, 1715.
5. Seeman, P.; Chau-Wong, M.; Tedsco, J.; Wong, K. Proc. Natl. Acad. Sci. USA 1975, 72, 4376-80.
6. Breier, A.; Su, T.-P.; Saunders, R.; Carson, R. E.; Kolachana, B. S.; De Bartolomeis, A.; Weinberger, D. R.; Weisenfeld, N.; Malhotra, A. K.; et al., e. Proc. Natl. Acad. Sci. U. S. A. 1997, 94, 2569-74.
7. Dolan, R. J.; Fletcher, P.; Frith, C. D.; Fristen, K. J.; Frackowiak, R. S. J.; Grasby, P. M. Nature (London) 1995, 378, 180-2.
8. Kebabian, J. W.; Calne, D. B. Nature 1979, 277, 93-6.
9. Euvrard, C.; Premont, J.; Oberlander, C.; Boissier, J. R.; Bockaert, J. Naunyn-Schmiedeberg's Arch. Pharmacol 1979, 309, 241-5.
10. Helmeste, D. M.; Seeman, P. Biochem. Pharmacol. 1983, 32, 741-4.
11. Sunahara, R. K.; Niznik, H. B.; Weiner, D. M.; Stormann, T. M.; Brann, M. R.; Kennedy, J. L.; Gelernter, J. E.; R., R.; Yang, Y.; Israel, Y.; Seeman, P.; O'Dowd, B. F. Nature 1990, 347, 80-3.
12. Grandy, D. K.; Marchionni, M. A.; Makan, H.; Stofko, R. E.; Alfano, M.; Prothingham, L.; Fischer, J. B.; Burke-Howie, K. J.; Bunzow, J. R.; Server, A. C.; Civelli, O. Proc. Natl. Acad. Sci USA 1989, 84, 9762-66.
13. Giros, B.; Martres, M. P.; Sokoloff, P.; Schwartz, J. C. C. R. l'Academie Sci., Ser. III 1990, 311, 501-8.
14. Van Toi, H. H. M.; Bunzow, J. R.; Guan, H. C.; Sunahara, R. K.; Seeman, P.; Niznik, H. B.; Civelli, O. Nature (London) 1991, 350, 610-14.
15. Sunahara, R. K.; Guan, H. C.; O'Dowd, B. F.; Seeman, P.; Laurier, L. G.; Ng, G.; George, S. R.; Torchia, J.; Van Toi, H. H. M.; Niznik, H. G. Nature 1991, 350, 614-9.